REGN UPCOMING DEADLINE: SueWallSt Alerts Regeneron Pharmaceuticals, Inc. Stockholders of Securities Class Action - Contact the Firm

$REGNPress releaseSep 1, 2026, 10:29 AM ETRead the release

Levi & Korsinsky LLP, operating as SueWallSt, issued a solicitation alerting Regeneron Pharmaceuticals investors to a pending securities class action concerning the period between August 2025 and May 2026. The lawsuit alleges that the company made misleading statements regarding the Phase III Fianlimab-Libtayo study, specifically concerning clinical differentiation risks and protocol amendments that preceded a stock price decline.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.